Rautenberg, Christina
Stölzel, Friedrich http://orcid.org/0000-0003-0653-5332
Röllig, Christoph
Stelljes, Matthias
Gaidzik, Verena
Lauseker, Michael http://orcid.org/0000-0002-6662-7127
Kriege, Oliver
Verbeek, Mareike
Unglaub, Julia Marie
Thol, Felicitas
Krause, Stefan W. http://orcid.org/0000-0002-5259-4651
Hänel, Mathias
Neuerburg, Charlotte
Vucinic, Vladan
Jehn, Christian-Friedrich
Severmann, Julia
Wass, Maxi
Fransecky, Lars
Chemnitz, Jens
Holtick, Udo
Schäfer-Eckart, Kerstin
Schröder, Josephine
Kraus, Sabrina
Krüger, William
Kaiser, Ulrich
Scholl, Sebastian
Koch, Kathrin
Henning, Lea
Kobbe, Guido
Haas, Rainer
Alakel, Nael
Röhnert, Maximilian-Alexander
Sockel, Katja http://orcid.org/0000-0003-1732-7299
Hanoun, Maher
Platzbecker, Uwe
Holderried, Tobias A. W.
Morgner, Anke
Heuser, Michael http://orcid.org/0000-0001-5318-9044
Sauer, Tim
Götze, Katharina S.
Wagner-Drouet, Eva
Döhner, Konstanze
Döhner, Hartmut
Schliemann, Christoph
Schetelig, Johannes
Bornhäuser, Martin
Germing, Ulrich
Schroeder, Thomas http://orcid.org/0000-0002-1653-7959
Middeke, Jan Moritz http://orcid.org/0000-0003-3250-293X
Article History
Received: 8 July 2021
Revised: 7 September 2021
Accepted: 17 September 2021
First Online: 4 October 2021
Competing interests
: T Schroeder: advisory boards, lecture fees from JAZZ Pharmaceuticals Germany. JMM: personal fee, advisory board from JAZZ Pharmaceuticals Germany. HD: Advisory Board with honoraria: AbbVie, Agios, Amgen, Astellas, Astex Pharmaceuticals, AstraZeneca, Berlin-Chemie, BMS, Celgene, GEMoaB, Gilead, Helsinn, Janssen, Jazz, Novartis, Oxford Biomedica, Roche; clinical research funding: Agios, Amgen, Astellas, Bristol Myers Squibb, Celgene, Jazz Pharmaceuticals, Novartis, Pfizer. KG: Advisory Board with honoraria: AbbVie, JAZZ, BMS/Celgene Deutschland GmbH, Alexion; research funding: BMS/Celgene. T Sauer: Advisory Board with honoraria: AbbVie, Takeda, Astellas. CR: financial travel support: JAZZ Pharmeceuticals and BMS/Celgene Deutschland GmbH; lecture fees: BMS/Celgene Deutschland GmbH. GK: received lecture fees from BMS/Celgene Deutschland GmbH, Novartis, Jazz Pharmaceuticals and Janssen-Cilag GmbH. FS: advisory board with honoraria: JAZZ Pharmaceuticals, AbbVie, medac GmbH. Ulrich Germing: research funding: BMS/Celgene Deutschland GmbH, Novartis.